Circulating MrgD in Pulmonary Hypertension

Recruiting

• Conditions: Pulmonary Hypertension
• Interventions: Diagnostic Test: Western blot

• Registration Number: NCT06365372
• Lead Sponsor: Qilu Hospital of Shandong University

Brief Summary

The aim of the study is to observe the change of the circulating MrgD level in patients with pulmonary hypertension compared with subjects without pulmonary hypertension.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-04
• Study Start: 2024-04-10
• Study First Submitted: 2024-04-10
• Study First Submitted QC: 2024-04-10
• Last Update Submitted: 2024-04-10
• Study First Posted: 2024-04-15
• Last Update Posted: 2024-04-15
• Primary Completion: 2024-05-10
• Study Completion: 2024-06-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
PAH	Western blot	-
Non-PAH	Western blot	-

Primary Outcome Measures

Name	Time	Method
Circulating MrgD level	From 2022 to 2024

Trial Locations

Locations (1)

Qilu Hospital of Shandong University; 🇨🇳 Jinan, Shandong, China